CINECA IRIS Institutional Research Information System

PANDOLFI DE RINALDIS, Pier Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5198
EU - Europa 4266
AS - Asia 2170
AF - Africa 14
OC - Oceania 12
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 11678
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5160
CN - Cina 1649
IE - Irlanda 742
SE - Svezia 657
IT - Italia 620
DE - Germania 551
FI - Finlandia 442
UA - Ucraina 346
KR - Corea 322
FR - Francia 239
DK - Danimarca 197
GB - Regno Unito 140
PL - Polonia 135
VN - Vietnam 112
AT - Austria 99
CA - Canada 29
JP - Giappone 29
BE - Belgio 25
NL - Olanda 13
SN - Senegal 12
GR - Grecia 11
HK - Hong Kong 11
TR - Turchia 9
TW - Taiwan 9
AU - Australia 8
EU - Europa 8
PT - Portogallo 8
RU - Federazione Russa 8
CH - Svizzera 7
NO - Norvegia 7
IR - Iran 6
PR - Porto Rico 6
IN - India 5
PH - Filippine 5
RO - Romania 5
ES - Italia 4
NZ - Nuova Zelanda 4
PE - Perù 4
BG - Bulgaria 3
BR - Brasile 3
MY - Malesia 3
PK - Pakistan 3
TH - Thailandia 3
CZ - Repubblica Ceca 2
MX - Messico 2
RS - Serbia 2
SG - Singapore 2
AZ - Azerbaigian 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
LU - Lussemburgo 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
SC - Seychelles 1
SI - Slovenia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 11678
Salva come PNG Salva come JPEG
Città #
Beijing 1071
Houston 828
Dublin 742
Chandler 691
Ann Arbor 430
Jacksonville 353
Hangzhou 309
Torino 272
Princeton 230
Fairfield 225
Medford 215
Wilmington 201
Villeurbanne 166
Boston 137
Warsaw 134
Dearborn 117
Ashburn 109
Woodbridge 108
Vienna 98
Seattle 91
Boardman 83
Dong Ket 65
Nyköping 64
Cambridge 61
San Mateo 55
Fremont 43
Milan 40
Norwalk 40
Pisa 38
Falls Church 34
Guangzhou 31
Nanjing 30
Düsseldorf 29
Redwood City 28
Shanghai 27
Brussels 21
Turin 21
Hefei 20
Verona 18
Zhengzhou 17
Mountain View 16
New York 15
Kunming 14
Munich 13
San Diego 11
Nürnberg 10
Toronto 10
Jinan 9
Rome 9
Central District 8
Montréal 8
Phoenix 8
Shenzhen 8
Taipei 8
Nanchang 7
Padova 7
Silver Spring 7
Des Moines 6
Fuzhou 6
La Jolla 6
Ottawa 6
Seoul 6
Stavanger 6
Wuhan 6
Changsha 5
Chongqing 5
London 5
Xian 5
Bologna 4
Chengdu 4
Grafing 4
Mcallen 4
Palaiseau 4
Paris 4
Piura 4
Redmond 4
Shenyang 4
Tianjin 4
Upper Marlboro 4
Chicago 3
Edinburgh 3
Fort Worth 3
Freiburg 3
Fucecchio 3
Hebei 3
Horia 3
Huzhou 3
Istanbul 3
Leawood 3
Melilla 3
Napoli 3
Perugia 3
Trento 3
Anaheim 2
Ariano nel Polesine 2
Baotou 2
Buffalo 2
Casal di Principe 2
Christchurch 2
Cirié 2
Totale 7622
Salva come PNG Salva come JPEG
Nome #
Morgana acts as an oncosuppressor in chronic myeloid leukemia. 408
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones 307
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology 284
Essential Role of the p110β Subunit of Phosphoinositide 3-OH Kinase in Male Fertility 243
Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs 221
Morgana is a new oncosuppressor in CML 216
Morgana/chp-1, a ROCK inhibitor involved in centrosome duplication and tumorigenesis 206
The RNA-binding protein ESRP1 promotes human colorectal cancer progression 195
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation 161
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. 153
An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance 153
Generation of Functional Hepatocytes from Mouse Germline Cell-derived Pluripotent Stem Cells in vitro 144
Generation of functional multipotent adult stem cells from GPR125+ germline progenitors 142
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer 137
A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells 129
An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer 121
DOK2 inhibits EGFR-mutated lung adenocarcinoma 120
Characterization and Analysis of the Composition and Dynamics of the Mammalian Riboproteome 113
INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS 106
The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo 104
Pseudogenes as competitive endogenous RNAs: target prediction and validation. 103
The proto-oncogene LRF is under post-transcriptional control of MiR-20a: implications for senescence. 101
PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity 97
Regulation of the p73 protein stability and degradation. 93
Inhibition OF USP7 Induces Selective Cancer Cell Death in Chronic Lymphocytic Leukemia 88
Morgana acts as a proto-oncogene through inhibition of a ROCK-PTEN pathway. 86
A novel signaling network as a critical rheostat for the biology and maintenance of the normal stem cell and the cancer-initiating cell. 83
Role of Dok-1 and Dok-2 in leukemia suppression. 81
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? 77
A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance. 75
MORGANA/CHP1 ACTS AS AN ONCOSUPPRESSOR IN CHRONIC MYELOID LEUKEMIA 75
BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP 74
Aberrant mRNA translation in cancer pathogenesis: an old concept revisited comes finally of age. 73
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate 73
A CK2-dependent mechanism for degradation of the PML tumor suppressor. 70
Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion 69
Bone marrow endosteal mesenchymal progenitors depend on HIF factors for maintenance and regulation of hematopoiesis. 69
Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction 68
A metabolic prosurvival role for PML in breast cancer. 67
Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. 64
Ubiquitination regulates PTEN nuclear import and tumor suppression. 63
Nuclear Akt2 opposes limbal keratinocyte stem cell self-renewal by repressing a FOXO-mTORC1 signaling pathway. 63
Therapeutic inhibition of HAUSP-PTEN network in chronic lymphocytic leukemia 63
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation. 62
Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis. 61
Nucleophosmin serves as a rate-limiting nuclear exportchaperone for the Mammalian ribosome 61
In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes 61
Repression of kit expression by Plzf in germ cells. 61
A novel signal transduction cascade involving directphysical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein 60
Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events. 60
Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments. 60
The Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation 59
Acetylation-dependent regulation of Skp2 function. 58
Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma. 58
The RNA binding protein ESRP1 fine-tunes the expression of pluripotency-related factors in mouse embryonic stem cells 57
PTEN self-regulates through USP11 via the PI3K-FOXO pathway to stabilize tumor suppression 57
The theory of APL revisited. 56
Two decades of cancer genetics: from specificity to pleiotropic networks. 56
Mouse modeling in oncologic preclinical and translational research. 56
NGF-promoted axon growth and target innervation requires GITRL-GITR signaling. 55
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. 55
A Role for PML in Innate Immunity. 55
The cytoplasmic NPM mutant induces myeloproliferation in atransgenic mouse model 55
Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes. 55
NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. 54
The transcription factor Pokemon: a new key player in cancer pathogenesis. 54
EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors. 54
Faithfull Modeling of PTEN Loss Driven Diseases in the Mouse 54
A novel type of cellular senescence that can be enhanced in mousemodels and human tumor xenografts to suppress prostate tumorigenesis 54
c-Abl phosphorylates Dok1 to promote filopodia during cell spreading. 53
Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes. 53
Treatment with 5-azacytidine accelerates acute promyelocytic leukemia leukemogenesis in a transgenic mouse model. 53
Subtle variations in Pten dose determine cancer susceptibility 52
Bcr-Abl p210 delocalizes PTEN through a PML/HAUSP network 52
Compound haploinsufficiency of Dok2 and Dusp4 promotes lung tumorigenesis 52
A continuum model for tumour suppression 51
Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis 51
CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor. 50
Ubiquitin-dependent degradation of p73 is inhibited by PML. 50
The PTEN-PI3K pathway: of feedbacks and cross-talks 50
Essential role for nuclear PTEN in maintaining chromosomal integrity. 50
APL as a paradigm in biomedical research: a journey toward the cure. 50
The role of PML in the control of apoptotic cell fate: a new key player at ER-mitochondria sites. 50
The pten–pi3k axis in cancer 50
Deregulated TGF-beta signaling in leukemogenesis. 49
AKT methylation by SETDB1 promotes AKT kinase activity and oncogenic functions 49
The mechanisms of PML-nuclear body formation. 48
Breaking the rules of cancer. 48
p18 Ink4c and Pten constrain a positive regulatory loop between cell growth and cell cycle control. 48
Ubiquitination of K-Ras enhances activation and facilitates binding to select downstream effectors. 48
TSPYL5 suppresses p53 levels and function by physical interaction with USP7 48
Deregulated PP1α phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanism 48
Haplo-insufficiency: a driving force in cancer 47
Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse. 47
The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. 47
Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation. 47
Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia. 46
Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB 46
The ceRNA world: a new way of looking at the role of different RNA molecules 46
PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR 46
Totale 8451
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23338
article - articoli 0
book - libri 0
conference - conferenze 1331
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24669
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201827 0000 00 00 00027
2018/2019818 33256299 3776 27128 344519458
2019/20202337 3257123231 170640 206109 275154192148
2020/20211644 210476795 163140 20139 152167152211
2021/20221752 625865197 9257 18098 7299220552
2022/20232347 30414844159 247667 290127 224251120
Totale 12307